ArticlePloS one2017

Mass spectrometry-based serum peptidome profiling accurately and reliably predicts outcomes of pemetrexed plus platinum chemotherapy in patients with advanced lung adenocarcinoma.

Lin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.